New IV fentanyl strategy aims to keep patients on opioid therapy longer
NCT ID NCT05905367
First seen Apr 15, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This study tested a new way to help people with opioid use disorder who use fentanyl. Participants received medically supervised IV fentanyl until they were comfortable, then switched to daily oral opioid medication. The goal was to see if this approach is safe and helps people stay on treatment longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope to Health Research & Innovation Centre
Vancouver, British Columbia, V6A 1H2, Canada
Conditions
Explore the condition pages connected to this study.